$1,500.00

TT SMAD/TGFbeta Reporter (Luc) stable cell line

Catalog number
CL-1467
Description
TT SMAD/TGFbeta Reporter (Luc) cells are derived from the human medullary thyroid carcinoma TT cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. TT cell line has been widely used in cancer research and drug development. TT SMAD/TGFbeta Reporter (Luc) cells express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for in vitro assays and in vivo imaging.

Product Details

Package Size 2 x 10^6 cells
Parental cell line TT cells
Transgenic gene Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2024, FenicsBIO. All rights reserved.